IP Library Granted Patent US 7,132,401
Granted Patent B2
US 7,132,401 · App. 10/480,954 · Granted Nov 7, 2006

Beta-secretase substrates and uses thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,132,401
App. No.
10/480,954
Granted
Nov 7, 2006
Kind
B2
Abstract

The present invention provides synthetic β-secretase peptide substrates useful in various assays for measuring β-secretase activity. Antibodies that recognize the synthetic substrates and uses of the antibodies in various assays are disclosed. The herein disclosed peptide substrates are hydrolyzed at rates substantially faster than the attendant Swedish mutant APP from which the substrate sequences are derived.

Claims (15)

1. A method for assaying for increased β-secretase activity comprising measuring a cleavage product produced from cleavage by β-secretase of an APP substrate comprising a β-secretase peptide substrate comprising a β-secretase cleavage site and having the formula P4-P3-P2-P1-P1′-P2′-P3′-P4′, where

P4 is selected from the group consisting of D, E, I, L and V;

P3 is selected from the group consisting of L, I, V and N;

P2 is selected from the group consisting of F, Y, E and N;

P1 is selected from the group consisting of F, I, L and Y;

P1′ is selected from the group consisting of A, E, S, I, L and D;

P2′ is selected from the group consisting of V, I, L and A;

P3′ is selected from the group consisting of V, I, L, E and Y; and

P4′ is selected from the group consisting of P, W and F;

where P4-P3-P2-P1-P1′-P2′-P3′-P4′ cannot simultaneously be chosen such that they comprise the Swedish mutation β-secreatse cleavage site (SEQ ID NO: 257); and

where an increase in β-secretase activity is determined when the amount of the cleavage product is increased relative to the amount of the cleavage product produced from an APP substrate having the Swedish mutation at said β-secretase cleavage site (SEQ ID NO: 257).

2. The method of claim 1 wherein said β-secretase peptide substrate corresponds to positions 593–600 of APP695.

3. The method of claim 2 wherein said β-secretase peptide substrate comprises SEQ ID NO: 262.

4. The method of claim 1 wherein the β-secretase activity is measured using an antibody that binds to the amino terminus of the β-CTF cleavage product.

5. The method of claim 1 wherein the cleavage product detected is β-CTF.

Assignments (2)
CHANGE OF NAME Recorded Jan 28, 2010
From: MERCK & CO., INC.
To: MERCK SHARP & DOHME CORP.
Reel/Frame 023861/0349 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 29, 2006
From: BRADY, STEPHEN F.; BRUCE, JAMES E.; CHEN-DODSON, ELIZABETH; GARSKY, VICTOR; LI, YUEMING; SARDANA, MOHINDER; SHAFER, JULES A.; TANG, XIAOTING
To: MERCK & CO., INC.
Reel/Frame 017405/0222 →